Ashiq Mubarack

Item: Ashiq Mubarack
Rating: 0.88
Author: StockAnalysis.com

Stock Analyst at Citigroup

(0.88)

# 3,790

Out of 4,893 analysts

Total ratings

66.67%

Success rate

-18.5%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$6 → $5	$0.34	+1,382.80%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$3.26	+145.40%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $6 → $5

Current: $0.34

Upside: +1,382.80%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $3.26

Upside: +145.40%